Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Shioi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Circulation|October 14, 2009
Suppression of phosphoinositide 3-kinase prevents cardiac aging in miceYasutaka Inuzuka, Junji Okuda, Tsuneaki Kawashima, et al.
Life Sciences|March 7, 2012
Effect of persistent activation of phosphoinositide 3-kinase on heartShinichiro Niizuma, Yasutaka Inuzuka, Junji Okuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2007
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathyJulie R McMullen, Fatemeh Amirahmadi, Elizabeth A Woodcock, et al.
Plos One|August 17, 2013
Persistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in miceJunji Okuda, Shinnichiro Niizuma, Tetsuo Shioi, et al.
Journal of Molecular and Cellular Cardiology|January 29, 2013
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblastsYodo Tamaki, Yoshitaka Iwanaga, Shinichiro Niizuma, et al.
Cell Metabolism|October 3, 2007
A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophyBrian T O'Neill, Jaetaek Kim, Adam R Wende, et al.
The American Journal of Pathology|August 15, 2009
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillationLynette Pretorius, Xiao-Jun Du, Elizabeth A Woodcock, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2010
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNARuby C Y Lin, Kate L Weeks, Xiao-Ming Gao, et al.
Molecular and Cellular Biology|December 24, 2014
Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genesAdam R Wende, Brian T O'Neill, Heiko Bugger, et al.
ESC Heart Failure|August 4, 2017
Kyoto Congestive Heart Failure (KCHF) study: rationale and designErika Yamamoto, Takao Kato, Neiko Ozasa, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Circulation|October 14, 2009
Suppression of phosphoinositide 3-kinase prevents cardiac aging in miceYasutaka Inuzuka, Junji Okuda, Tsuneaki Kawashima, et al.
Life Sciences|March 7, 2012
Effect of persistent activation of phosphoinositide 3-kinase on heartShinichiro Niizuma, Yasutaka Inuzuka, Junji Okuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2007
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathyJulie R McMullen, Fatemeh Amirahmadi, Elizabeth A Woodcock, et al.
Plos One|August 17, 2013
Persistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in miceJunji Okuda, Shinnichiro Niizuma, Tetsuo Shioi, et al.
Journal of Molecular and Cellular Cardiology|January 29, 2013
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblastsYodo Tamaki, Yoshitaka Iwanaga, Shinichiro Niizuma, et al.
Cell Metabolism|October 3, 2007
A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophyBrian T O'Neill, Jaetaek Kim, Adam R Wende, et al.
The American Journal of Pathology|August 15, 2009
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillationLynette Pretorius, Xiao-Jun Du, Elizabeth A Woodcock, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2010
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNARuby C Y Lin, Kate L Weeks, Xiao-Ming Gao, et al.
Molecular and Cellular Biology|December 24, 2014
Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genesAdam R Wende, Brian T O'Neill, Heiko Bugger, et al.
ESC Heart Failure|August 4, 2017
Kyoto Congestive Heart Failure (KCHF) study: rationale and designErika Yamamoto, Takao Kato, Neiko Ozasa, et al.
Pageof 5